Inovet is a veterinary pharmaceutical company active worldwide and dedicated to research, production and marketing of veterinary pharmaceuticals and animal health products. Inovet has divisions in Belgium (V.M.D. nv/sa), France (Laboratoires Biové S.A.S.), Hungary (V.M.D. Állatgyógyászati Kft), and Vietnam (Inovet Indochine). Inovet is part of the Orion Group. Inovet offers over 220 different pharmaceutical products and over 1,200 international marketing authorizations, under the umbrella of two leading veterinary brands: VMD® Livestock pharma and Biové® Laboratoires. Inovet provides an extensive range of registered antibiotics, chemotherapeutics, vitamins, local anesthetics, anti-inflammatory, analgesic, antipyretic agents, hormonal, and anti-parasitic products in the form of injectable preparations, water-soluble powders, oral solutions, and premixes. The production facility of Inovet (Laboratoires Biové S.A.S.) is located in Arques, France. The facility has four production units for pharmaceutical products: injectable solutions and suspensions, oral powders, oral liquids, and anti-parasitic products (powders, solutions, and collars). A fifth unit is dedicated to the production of complementary feeds. In addition to the production of the group’s own brands, Inovet offers extensive toll manufacturing services.
There is no investment information
No recent news or press coverage available for Inovet.